The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC).
 
Thierry Andre
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pierre Fabre; Roche/Genentech; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Pierre Fabre; Seagen; SERVIER; Servier; Tesaro; Transgene
Travel, Accommodations, Expenses - MSD Oncology
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; Gercor
 
Caterina Sposetti
No Relationships to Disclose
 
Mahmut Gumus
Honoraria - MSD Oncology (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Joong Bae Ahn
Consulting or Advisory Role - Ono Pharmaceutical
 
Lucjan Wyrwicz
Consulting or Advisory Role - BeiGene; GlaxoSmithKline
Research Funding - AstraZeneca; BeiGene; Bristol-Myers Squibb; MSD; Roche
 
Mariusz Kwiatkowski
No Relationships to Disclose
 
Jong Gwang Kim
No Relationships to Disclose
 
Suayib Yalcin
Honoraria - Abbott; Amgen; Gen; Merck Serono; Natera; Novartis; Pfizer
Consulting or Advisory Role - Abbott; Amgen; Merck Serono; Pfizer
Speakers' Bureau - Abbott; Amgen; Eczacibasi; Gen; Merck Serono; Roche
Travel, Accommodations, Expenses - amgen; Gen; Roche
 
Mehmet A.N. Sendur
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
 
Amos Odeleye-Ajakaye
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Pierre Leconte
Employment - MSD Oncology
Stock and Other Ownership Interests - MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology
 
David R. Fogelman
Employment - Merck
Stock and Other Ownership Interests - GTx; Merck
 
Tae Won Kim
Employment - Asan Medical Center
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); Sanofi (Inst)